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Introduction
The MRI contrast media manganese-dipyridoxyl-diphos-
phate (MnDPDP) has been shown to be a marker of via-
bility in patients with myocardial infarction, as
manganese-ions follow the calcium-pathways and accu-
mulate in viable myocardial cells. However, the contrast-
to-noise ratio is presently too low for clinical use. In a pre-
vious study in rats given manganese-cloride (MnCl2),
dobutamine increased the myocardial uptake of Mn sig-
nificantly.
Purpose
To study if a dobutamine-induced increase in contractil-
ity, giving increased calcium-cycling, would increase the
uptake of Mn in healthy human myocardium.
Methods
Twelve healthy subjects were randomized into two
groups. Both groups were given a 5-min infusion of 5
μmol/kg MnDPDP. In addition, one of the groups (n = 6)
also got at 10-min infusion of low-dose dobutamine (10
mikrog/kg/min), starting at the onset of the MnDPDP-
infusion. Myocardial Mn-uptake was quantified by R1-
measurements by MRI (1.5 T) before and 50 min after
start of the infusions. Heart rate and blood pressure were
monitored during the experiments.
Results
There were no adverse events. The double product (HR ×
blood pressure) increased in the Dobutamine group only
(p < 0.05), indicating increased contractility. Delta R1-val-
ues showed no significant difference in the myocardial
uptake of Mn in the two groups (Dobutamine vs. Control:
0.33 ± 0.04 vs. 0.37 ± 0.02, p = 0.078. Higher values indi-
cate higher uptake).
Conclusion
Differences in calcium-cycling in humans and rodents,
and possibly limited availability of free manganese-ions
in vivo, might explain the lack of increase in myocardial
contrast uptake after dobutamine seen in this study. Fur-
ther pharmacokinetic studies are needed to develop the
method.
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